Status of triatomines after bioassays | |||||
---|---|---|---|---|---|
Treatment group | Potentially exposeda | Blood-fedb | Fully engorged | Semi-engorged | Non-fedc |
Treated (3 dogs each) | |||||
Bravecto® | 225 | 202 | 153 | 49 | 23 |
Comfortis® | 230 | 194 | 97 | 97 | 36 |
NexGard® | 227 | 181 | 87 | 94 | 46 |
Total | 682 | 577 | 337 | 240 | 105 |
Control (1 dog each) | |||||
Bravecto® | 75 | 65 | 33 | 32 | 10 |
Comfortis® | 75 | 65 | 36 | 29 | 10 |
NexGard® | 75 | 61 | 24 | 37 | 14 |
Total | 225 | 191 | 93 | 98 | 34 |
Overall total | 907 | 768 | 430 | 338 | 139 |